The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis in women, according to study findings.

A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...

Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...

The Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.